glp 1 what to expect first week in your month on a GLP‑1: a week-by-week guide switching glp 1 3 Takeaways

Food and Drug Administration has granted Breakthrough Therapy Designation to our investigational glucagon/GLP-1 dual receptor agonist for the treatment of patients with metabolic dysfunction-associated steatohepatitis (MASH)

These genetic insights may help provide context for why your maintenance dose requirements differ from published averages or from what your peer group experiences

The skin is the second most frequently affected organ system in systemic lupus erythematosus (SLE), with cutaneous manifestations occurring in 70% to 85% of individuals over the course of the disease and as a presenting symptom in up to 25% of patients

Dose-response and pharmacokinetics Research to characterize absorption, distribution, metabolism, and excretion in reproductive organs, as well as safe dose ranges and optimal delivery routes for focused targeting of gonadal tissue without systemic exposure